Jeanny Aragon-Ching, MD, Inova Schar Cancer Institute
Advertisement
Articles by Jeanny Aragon-Ching, MD, Inova Schar Cancer Institute
Advertisement
Latest Updated Articles
Increased Survival Outcomes with Switch Maintenance in mUCAugust 26th 2020
Changing the Standard of Care in Metastatic Bladder CancerAugust 26th 2020
Safety Data from JAVELIN Bladder 100August 26th 2020
Sequencing Considerations in mUC after Frontline IOAugust 26th 2020
Current Status of Therapy: Metastatic Urothelial CancerAugust 26th 2020
PD-L1 Expression in Metastatic Urothelial CancerAugust 26th 2020
Advertisement
Advertisement
Trending on OncLive
1
FDA Grants Priority Review to Giredestrant for ER-Positive Early Breast Cancer
2
Bispecific-Based Approaches Highlight Key Multiple Myeloma Data Set to Emerge at EHA 2026
3
Breast Cancer Experts Spotlight Practice-Informing and Thought-Provoking Data From ASCO 2026
4
CELMoDs and Bispecifics Break Through Across Lymphomas and Leukemias at EHA 2026
5